FIELD: biotechnology.
SUBSTANCE: described is a peptide which binds with a molecule(s) of a major histocompatibility complex (MHC) selected from: (a) a peptide consisting of an amino acid sequence according to SEQ ID NO: 30, optionally elongated per 1 amino acid on its N- and/or C-terminal portion; (b) a peptide according to (a), where said peptide contains non-peptide bonds. Described also is a fused peptide, a kit and a pharmaceutical composition containing said peptide. Disclosed are nucleic acid, vector, host cell corresponding to described peptide.
EFFECT: invention expands the arsenal of cancer treatments.
20 cl, 6 dwg, 27 tbl, 6 ex
| Title |
Year |
Author |
Number |
| ANTIGENE PEPTIDES FOR CANCER PREVENTION AND TREATMENT |
2019 |
- Chene Laurent
- Bonny Christophe
- Strozzi Francesco
|
RU2812911C2 |
| VACCINE COMPOSITION FOR TREATMENT OF CANCER |
2018 |
- Nikosia, Alfredo
- Skarselli, Elisa
- D'Alise, Anna Morena
|
RU2782261C2 |
| PEPTIDES IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS FOR USE IN TREATING CANCER |
2020 |
- Kholst, Peter Jokhannes
- Akselsson, Lena
- Andersson, Tommi
|
RU2826955C2 |
| PEPTIDE OBTAINED FROM GPC3, PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER USING IT, IMMUNITY INDUCER AND METHOD FOR PRODUCING ANTIGEN-PRESENTING CELLS |
2016 |
- Udaka, Keiko
- Tamada, Koji
- Hazama, Shoichi
- Oka, Masaaki
- Miyakawa, Tomoya
|
RU2714117C2 |
| MULTIVALENT IMMUNOTHERAPEUTIC COMBINATION AND METHODS OF USE FOR TREATING WT1-POSITIVE CANCERS |
2020 |
- Stergiou, Angelos, M.
- Sarlis, Nicholas, J.
- Scheinberg, David, A.
- Dao, Tao
|
RU2827874C2 |
| NEIL3 PEPTIDES AND VACCINES COMPRISING THEM |
2010 |
- Tsunoda, Takuya
- Ohsawa, Ryuji
- Yoshimura, Sachiko
- Watanabe, Tomohisa
- Nakamura, Yusuke
- Furukawa, Yoichi
|
RU2733985C2 |
| T-CELL COMPOSITIONS WITH T-CELL RECEPTOR DEFICIENCY |
2013 |
|
RU2781979C2 |
| HUMAN MONOCLONAL ANTIBODIES TO THE PROTEIN OF PROGRAMMED DEATH 1 (PD-1) AND METHODS OF TREATING CANCER USING ANTI-PD-1 ANTIBODIES ALONE OR IN COMBINATION WITH OTHER IMMUNOTHERAPEUTIC AGENTS |
2016 |
- Korman Alan Dzh.
- Srinivasan Mokhan
- Van Chanyuj
- Selbi Mark Dzh.
- Chen Bin
- Kardarelli Zhozefin M.
|
RU2732924C2 |
| COMPOSITIONS AND METHODS FOR DIAGNOSTICS AND TREATMENT OF TUMOUR |
2010 |
- Dehnnis Mark
- Polakis Pol
- Rubinfeld Bonni
|
RU2563359C2 |
| IMMUNE CELLS EXPRESSING INVERSE UNIVERSAL CHIMERIC ANTIGEN RECEPTOR, FOR TARGETING VARIOUS MULTIPLE ANTIGENS AND METHOD FOR PRODUCTION AND USE THEREOF FOR TREATING CANCER, INFECTIONS AND AUTOIMMUNE DISEASES |
2019 |
|
RU2824391C2 |
